… Respondents were not eligible to participate in BURDEN IBS-C if they had CIC, irritable
bowel syndrome with diarrhea or mixed diarrhea and constipation, inflammatory bowel disease, …

… Introduction: Linaclotide (LIN), a guanylate cyclase-C (GC-C) agonist, is currently approved
for the treatment of adults with irritable bowel syndrome with constipation (IBS-C; dosage …

The purpose of this study was to gain in-depth understanding of what it is like for a person
with irritable bowel syndrome to be in the patient position in encounters with health care …

… irritable bowel syndrome with constipation (IBS-C), and had not been previously diagnosed
as having any disease of organic cause with associated constipation (eg, gastrointestinal, …

… Few respondents (28.7%) recognized that abdominal pain is the cardinal symptom of IBS,
and … This apparent disconnect may reflect patient reliance on medications, lack of information …

… Throughout the history of medicine, clinicians have recognized … significant, yet under-recognized.
They are also inseparable from … There is a significant disconnect between the views of …

… with traditional beliefs, there will be a profound disconnect in the treatment approach. In the
book … We frequently encounter this in our patients and feel that recognition and discussion of …

… We surveyed 50 international gastroenterologists (GIs) who are recognized experts in IBS. …
or how this disconnect should be remedied. On the one hand, the disconnect may reflect poor …

… Acute inflammation damages enteric nerves and disconnects them from their gut targets. As
… Bile salt malabsorption, long recognized in IBD, is also now recognized to be important in …

… In light of the disconnect between FDA guidance and the level of evidence supporting …
practice and clinical trials, were not widely recognized by patients in our cognitive interviews. The …